Of importance, patients with AF treated with antiplatelet therapy, inhibitors of cyclooxygenase 2, other NSAIDs, or PPIs or being active smokers would have been regularly reminded by physicians about the significance of OACs in stroke prevention [3]. This evidence concerns the gene PTGS2 and stroke disorder.